Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.21.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Income Statement [Abstract]    
Revenue $ 0 $ 121
Operating expenses:    
Research and development 36,522 38,394
Selling, general and administrative 14,627 10,648
Total operating expenses 51,149 49,042
Loss from operations (51,149) (48,921)
Other expense (income):    
Loss on extinguishment of debt 1,766 1,045
Amortization of debt issuance costs and discount 1,201 1,171
Interest income (189) (805)
Interest expense 1,181 986
Other income (334) (538)
Other expense 602 0
Warrant liabilities fair value adjustment 5,214 4,497
Derivative liability fair value adjustment (2,257) (1,567)
Total other expense: 7,184 4,789
Loss before taxes (58,333) (53,710)
Income tax benefit 3,148 0
Net loss $ (55,185) $ (53,710)
Net loss per share – basic and diluted $ (5.15) $ (9.58)
Weighted average common shares outstanding – basic and diluted 10,720,211 5,608,138